Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J LORD

Showing results (501-510 of 511) with videos related to

Pageof 52
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2022
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor ResistanceVioleta Serra, Anderson T Wang, Marta Castroviejo-Bermejo, et al.
Nature Genetics|September 25, 2012
Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer riskNick Orr, Alina Lemnrau, Rosie Cooke, et al.
The New England Journal of Medicine|October 29, 2015
DNA-Repair Defects and Olaparib in Metastatic Prostate CancerJoaquin Mateo, Suzanne Carreira, Shahneen Sandhu, et al.
Cell Reports|May 14, 2020
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic CancerHolly Brunton, Giuseppina Caligiuri, Richard Cunningham, et al.
Cancer|March 6, 2019
Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special ConferenceRobert C Bast, Ursula A Matulonis, Anil K Sood, et al.
JAMA Oncology|December 18, 2025
Enhancing Clinical Cancer Research Through Sharing of Data and BiospecimensHans Wildiers, Virginie Adam, Seamus O'Reilly, et al.
The FEBS Journal|July 29, 2021
ADP-ribosyltransferases, an update on function and nomenclatureBernhard Lüscher, Ivan Ahel, Matthias Altmeyer, et al.
Circulation|November 16, 2017
ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical PathwayMartin P Than, John W Pickering, Jeremy M Dryden, et al.
Nature Communications|June 18, 2021
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistanceDiana Zatreanu, Helen M R Robinson, Omar Alkhatib, et al.
Nature|December 18, 2012
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancerElise Ruark, Katie Snape, Peter Humburg, et al.
Pageof 52

Showing results (501-510 of 511) with videos related to

Sort By:
Pageof 52
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2022
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor ResistanceVioleta Serra, Anderson T Wang, Marta Castroviejo-Bermejo, et al.
Nature Genetics|September 25, 2012
Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer riskNick Orr, Alina Lemnrau, Rosie Cooke, et al.
The New England Journal of Medicine|October 29, 2015
DNA-Repair Defects and Olaparib in Metastatic Prostate CancerJoaquin Mateo, Suzanne Carreira, Shahneen Sandhu, et al.
Cell Reports|May 14, 2020
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic CancerHolly Brunton, Giuseppina Caligiuri, Richard Cunningham, et al.
Cancer|March 6, 2019
Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special ConferenceRobert C Bast, Ursula A Matulonis, Anil K Sood, et al.
JAMA Oncology|December 18, 2025
Enhancing Clinical Cancer Research Through Sharing of Data and BiospecimensHans Wildiers, Virginie Adam, Seamus O'Reilly, et al.
The FEBS Journal|July 29, 2021
ADP-ribosyltransferases, an update on function and nomenclatureBernhard Lüscher, Ivan Ahel, Matthias Altmeyer, et al.
Circulation|November 16, 2017
ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical PathwayMartin P Than, John W Pickering, Jeremy M Dryden, et al.
Nature Communications|June 18, 2021
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistanceDiana Zatreanu, Helen M R Robinson, Omar Alkhatib, et al.
Nature|December 18, 2012
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancerElise Ruark, Katie Snape, Peter Humburg, et al.
Pageof 52